995 related articles for article (PubMed ID: 32541923)
1. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
Dehlin M; Jacobsson L; Roddy E
Nat Rev Rheumatol; 2020 Jul; 16(7):380-390. PubMed ID: 32541923
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
[TBL] [Abstract][Full Text] [Related]
3. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
[TBL] [Abstract][Full Text] [Related]
4. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
Eliseev MS; Novikova AM
Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
[TBL] [Abstract][Full Text] [Related]
5. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care.
Choi HK; McCormick N; Yokose C
Nat Rev Rheumatol; 2022 Feb; 18(2):97-111. PubMed ID: 34921301
[TBL] [Abstract][Full Text] [Related]
6. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
[TBL] [Abstract][Full Text] [Related]
7. Gout.
Dalbeth N; Gosling AL; Gaffo A; Abhishek A
Lancet; 2021 May; 397(10287):1843-1855. PubMed ID: 33798500
[TBL] [Abstract][Full Text] [Related]
8. Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol.
Wen YF; Culhane-Pera KA; Pergament SL; Moua Y; Vue B; Yang T; Lo M; Sun B; Knights D; Straka RJ
PLoS One; 2023; 18(2):e0279830. PubMed ID: 36724193
[TBL] [Abstract][Full Text] [Related]
9. Overview of hyperuricaemia and gout.
Masseoud D; Rott K; Liu-Bryan R; Agudelo C
Curr Pharm Des; 2005; 11(32):4117-24. PubMed ID: 16375732
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study.
Ting K; Gill TK; Keen H; Tucker GR; Hill CL
Intern Med J; 2016 May; 46(5):566-73. PubMed ID: 26765205
[TBL] [Abstract][Full Text] [Related]
11. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
Robinson PC; Horsburgh S
Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
[TBL] [Abstract][Full Text] [Related]
12. [Gout and cardiovascular risk].
Němec P
Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
Gupta MK; Singh JA
Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
[TBL] [Abstract][Full Text] [Related]
14. Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
Shmerling RH
JAMA; 2012 Nov; 308(20):2133-41. PubMed ID: 23188030
[TBL] [Abstract][Full Text] [Related]
15. Gout: an update.
Eggebeen AT
Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
[TBL] [Abstract][Full Text] [Related]
16. Gout.
Dalbeth N; Merriman TR; Stamp LK
Lancet; 2016 Oct; 388(10055):2039-2052. PubMed ID: 27112094
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout.
Gerritsen M; Nurmohamed MT
Drugs Aging; 2024 Apr; 41(4):319-328. PubMed ID: 38416394
[TBL] [Abstract][Full Text] [Related]
18. Gout - An update of aetiology, genetics, co-morbidities and management.
Robinson PC
Maturitas; 2018 Dec; 118():67-73. PubMed ID: 30415758
[TBL] [Abstract][Full Text] [Related]
19. The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.
Rai SK; Aviña-Zubieta JA; McCormick N; De Vera MA; Shojania K; Sayre EC; Choi HK
Semin Arthritis Rheum; 2017 Feb; 46(4):451-456. PubMed ID: 28040245
[TBL] [Abstract][Full Text] [Related]
20. Chronic gout: epidemiology, disease progression, treatment and disease burden.
Brook RA; Forsythe A; Smeeding JE; Lawrence Edwards N
Curr Med Res Opin; 2010 Dec; 26(12):2813-21. PubMed ID: 21050059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
